Heme oxygenase: A target gene for anti-diabetic and obesity

Current Pharmaceutical Design

Volumn 14, Issue 5, 2008, Pages 412-421

  Abraham, Nader G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Adiponectin; Bilirubin; Carbon monoxide; Diabetes; HO 1; IL 1; Inflammation; TNF

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ADIPONECTIN; ANTIHYPERTENSIVE AGENT; BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; CURCUMIN; HEME ARGINATE; HEME OXYGENASE 1; HEME OXYGENASE 2; HEMIN; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LOSARTAN; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PROBUCOL; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN TIN; RAPAMYCIN; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE INTERMITTENT PORPHYRIA; ADD ON THERAPY; ADIPONETIN BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETOGENESIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME INDUCTION; ERYTHEMA; HEART MITOCHONDRION; HEME DEGRADATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PORPHYRIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ADIPONECTIN; ANIMALS; CYTOKINES; DIABETES MELLITUS; GENETIC ENHANCEMENT; HEME OXYGENASE-1; HUMANS; OBESITY; OXIDATIVE STRESS;

EID: 42049122627     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783597371     Document Type: Review

References (143)

1. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005; 39: 1-25.
2. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
3. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: Identification of iNOS-expressing cells and relationships to cytokines expressed in the islets. Endocrinology 1996; 137: 2093-9.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin dependent diabetes mellitus. N Eng J Med 1993; 320: 977-96.
5. Wolff SP. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993; 49: 642-52.
6. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
7. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 1994; 16: 383-91.
8. Bottino R, Balamurugan AN, Bertera S, Pietropaolo M, Trucco M, Piganelli JD. Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 2002; 51: 2561-7.
9. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, et al. Hyperglycomia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 1999; 48: 927-32.
10. Eizirik DL, Flodstrom. M, Karlsen AE, Welsh N. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 1996; 39: 875-90.
11. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, et al. Home oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001; 50: 1983-91.
12. Kaneto H, Fujii J, Seo, HG, Suzuki K, Matsuoka T, Nakamura M, et al. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 1995; 44: 733-8.
13. Kurrer MO, Pakala SV, Hanson HL, Katz JD. Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 1997; 94: 213-8.
14. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997; 46: 750-7.
15. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA, Jr., et al. The role of Fas in autoimmune diabetes. Cell 1997; 89: 17-24.
16. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 1997; 186: 613-8.
17. National diabetes fact sheet: General information and national estimates on diabetes in the United States. CDC 2005.
18. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005; 28: 1599-603.
19. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
20. Fonseca VA. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus. Am J Med 2007; 120: S18-S25.
21. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-4.
22. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-9.
23. Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, et al. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics 2006; 61: 433-40.
24. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, et al. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 2005; 111: 3126-34.
25. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular vascular disease. Circ Res 2005; 96: 939-49.
26. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome. J Am Coll Cardiol 2005; 46: 1978-85.
27. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2549-56.
28. Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 2006; 281: 8748-55.
29. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-51.
30. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-82.
31. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: A candidate gene for the insulin resistance syndrome. Diabetes 2002; 51: 2325-8.
32. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55: 249-59.
33. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83
34. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
35. Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007; 74: 11-8.
36. Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, et al. Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome. Atherosclerosis 2006; [epub ahead of print].
37. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45021-6.
38. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-91.
39. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-70.
40. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-6.
41. Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, et al. Effect of antihypenensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology (Carlton) 2007; 12: 147-53.
42. Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, et al. Adiponectin deficiency increases leukocyte-endothelium inter-actions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 2007; 117: 1718-26.
43. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52: 1655-63.
44. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock U, et al. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated. receptors. Arterioscler Thromb Vasc Biol 2007; 27: 1276-82.
45. Abraham NG, Kappas A. Pharmacological and Physiological Role of Heme Oxygenase In Normal and Pathological Circumstances. Pharmacol Rev 2007; (submitted).
46. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, et al. Heme Oxygenase-1 Attenuates Glucose-Mediated Cell Growth Arrest and Apoptosis in Human Microvessel Endothelial Cells. Circ Res 2003; 93: 507-14.
47. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li VG, et al. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 2004; 287: H2468-77.
48. L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, et al. Beneficial effect of heme oxygenase-1 expression in myocardial ischemia-reperfusion increases adiponectin in mildly diabetic rats. Am J Phyisiol Heart Circ Physiol 2007; 293: H3532-41.
49. Jung TW, Lee JY, Shim WS, Kang ES, Kim JS, Ahn CW, et al. Adiponectin protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity. Biochem Pharmacol 2006; 72: 616-23
50. da Silva JI, Stoltz R.A, Dunn MW, Abraham NG, Shibahara S. Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR. Curr Eye Res 1997; 16: 380-6.
51. Bruce CR, Carey AL, Hawley JA, Febbraio MA. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: Evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003; 52: 2338-45
52. Adaikalakoteswari A, Balasubramanyam M, Rema M, Mohan V. Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy. Diabet Med 2006; 23: 666-74.
53. Murphy RC, Falck JR, Lumin S, Yadagiri, P, Zirrolli JA, Balazy M, et al. 12[R]-hydroxyeicosatrienoic acid: A vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epithelium. Biol Chem 1988, 263: 17197-202.
54. Quan S, Kaminski PM, Yang L, Morita T, Inaba M, Ikehara S, et al. Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 2004; 315: 509-16.
55. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 2005; 289: H701-H707.
56. Ahmad M, Turkseven S, Mingone CJ, Gupte SA, Wolin MS, Abraham NG. Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. Cell Mol Biol (Noisy -le-grand] 2005; 51: 371-6.
57. Di Pascoli M, Rodella L, Sacerdoti D, Bolognesi M, Turkseven S, Abraham NG. Chronic CO levels have [corrected] a beneficial effect on vascular relaxation in diabetes. Biochem Biophys Res Commun 2006; 340: 935-43.
58. Robertson RP, Zhang HJ, Pyzdrowski KL, Walseth TF. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 1992; 90: 320-5.
59. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, et al. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 2003; 93: 507-14.
60. Zou MH, Shi C, Cohen RA. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H2 receptor-mediated apoptosis and adhesion molecular expression in cultured human aortic endothetial cells. Diabetes 2002, 51: 198-203.
61. Ceriello A, dello RP, Amstad P, Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 1996; 45: 471-7
62. Sacerdoti D, Olszanecki R, Li VG, Colombrita C, Scapagnini G, Abraham NG. Heme oxygenase overexpression attenuates glucose-mediated oxidative stress in quiescent cell phase: Linking heme to hyperglycemia complipations. Curr Neurovasc Res 2005; 2: 103-11.
63. Di Noia MA, Van DS, Palmieri F, Yang LM, Quan S, Goodman AI, et al. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J Biol Chem 2006; 281: 15687-93.
64. Kappas A. Development of heme oxygenase inhibitors for the prevention of sever jaundice in infants: Studies from laboratory bench to newborn nursery. In: Abraham NG, Alam J, Nath KA, editors. Heme Oxygenase in Biology and Medicine. New York, NY: Kluwer Academic/Plenum Publishers 2002; pp. 3-17.
65. Kruger AL, Peterson SJ, Schwartzman ML, Fusco H, McClung JA, Weiss M, et al. Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther 2006; 319: 1144-52
66. Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, Rodella LF, et al. Long-term treatment with die apolipoprotein Al mimetic Peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 2007; 322: 514-20.
67. Goodman AI, Chander PN, Rezzani R, Schwartzman ML, Regan RF, Rodella L, et al. Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J Am Soc Nephrol 2006; 17: 1073-81.
68. Shen X, Zheng S, Thongboonkerd V, Ru M, Pierce WM, Jr., Klein JB, et al. Cardiac mitochondrial damage and biogenesis in a chronic model of type I diabetes. Am J Physiol Endocrinol Metab 2004; 287: E896-E905.
69. Rosenberg MJ, Agarwala R, Bouffard G, Davis J, Fiermonte G, Hilliard MS, et al. Mutant deoxynucleotide carrier is associated with congenital microcephaly. Nat Genet 2002; 32: 175-9.
70. Stanley CA, Hale DE, Berry GT, Deleeuw S, Boxer J, Bonnefont JP. Brief report: A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med 1992; 327: 19-23.
71. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005; 54: 1926-33.
72. Hsieh RH, Lien LM, Lin SH, Chen CW, Cheng HJ, Cheng HH. Alleviation of oxidative damage in multiple tissues in rats with streptozotocin-induced diabetes by rice bran oil supplementation. Ann N Y Acad Sci 2005; 1042: 365-71.
73. Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E, Wiernsperger N, et al. Metformin prevents high-glucose-induced endothelial cell death through a mitoctiondrial permeability transidon-dependent process. Diabetes 2005; 54: 2179-87.
74. Turkseven S, Drummond G, Rezzani R, Rodella L, Quan S, Ikehara S, et al. Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway. J Cell Biochem 2007; 100: 815-23.
75. Li M, Peterson S, Husney D, Inaba M, Guo K, Terada, E, et al, Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: Possible role of carbon monoxide and bilirubin. Antioxid Redox Signal 2007; 9: 855-63.
76. Li M, Peterson S, Husney D, Inaba M, Guo K, Kappas A, et al. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 2007; 6: 567-71.
77. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Pre-conditioning the diabetic heart: The importance of akt phosphorylation. Diabetes 2005; 54: 2360-4.
78. Varma S, Lal BK, Zheng R, Breslin JW, Saito S, Pappas PJ, et al. Hyperglycemia Alters PI3k and Akt Signaling and Leads to Endothelial Cell Proliferative Dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H1744-51.
79. Kowluru A. Novel regulatory roles for protein phosphatase-2A in the islet beta cell. Biochem Pharmacol 2005; 69: 1681-91.
80. Dai C, Li Y, Yang J, Liu Y. Hepatocyte growth factor preserves beta cell mass and mitigates hyperglycemia in streptozotocin-induced diabetic mice. J Biol Chem 2003; 278: 27080-7.
81. Huang TJ, Sayers NM, Verkhratsky A, Fernyhough P. Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats. Exp Neurol 2005; 194: 279-83.
82. Bojunga J, Nowak D, Mitrou PS, Hoelzer D, Zeuzem S, Chow KU. Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 2004; 47: 2072-80.
83. Sun F, Kawasaki E, Akazawa S, Hishikawa Y, Sugahara K, Kamihira S, et al. Apoptosis and its pathway in early post-implantation embryos of diabetic rats. Diabetes Res Clin Prict 2005; 67: 110-8.
84. Chen W, Salojin KV, Mi QS, Grattan M, Meagher TC, Zucker P, et al. Insulin-like growth factor (IGf)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology 2004; 145: 627-38.
85. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000; 49: 1932-8.
86. Huang TJ, Verkhratsky A, Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol Cell Neurosci 2005; 28: 42-54.
87. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 2001; 15: 1406-18.
88. Hu CM, Lin HH, Chiang MT, Chang PF, Chau LY. Systemic expression of heme-oxygenase-1 ameliorates type I diabetes in NOD mice. Diabetes 2007; 56: 1240-7.
89. Abraham NG, Drummond G. CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflammatory function. Circ Res 2006; 99: 911-4.
90. Salinas M, Diaz R, Abraham NG, Ruiz De Galarreta CM, Cuadrado A. Nerve growth factor protects against 6-hydroxydopa-mine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem 2003; 278: 13898-904.
91. Nascimento AL, Luscher P, Tyrrell RM. Ultraviolet A (320-380 nm) radiation causes an alteration in the binding of a specific protein/ protein complex to a short region of the promoter of the human heme oxygenase 1 gene. Nucleic Acids Res 1993; 21: 1103-9.
92. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94: 10925-30.
93. Dennery PA, Spitz DR, Yang G, Tatarov A, Lee CS, Shegog ML, et al. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest 1998; 101: 1001-11.
94. Quan S, Yang L, Abraham NG, Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci USA 2001; 98: 12203-8.
95. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I. Cytotoxic effects of cytokines on rat islets: Evidence for involvement of free radicals and lipid peroxidation. Diabetologia 1992; 35: 409-13.
96. Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005; 327: 1066-71.
97. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, Chung KR, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172: 4744-51.
98. Chen S, Kapturczak ME, Wasserfall C, Glushakova OY, Campbell-Thompson M, Deshane JS, et al. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci USA 2005; 102: 7251-6
99. Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 2005; 106: 1694-702.
100. Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol 2007; 71: 817-25.
101. Harrison EM, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ. Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in renal cells. FEBS J 2006; 273: 2345-56.
102. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: Insights from therapeutic interventions. J Am Coll Cardiol 2005; 46: 1978-85.
103. da Silva JL, Morishita T, Escalante B, Staudinger R, Drummond G, Goligorsky MS, et al. Dual role of heme oxygenase in epithelial Cell injury: Contrasting effects of short-term and long-term exposure to oxidant stress. J Lab Clin Med 1996; 128: 290-6.
104. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989; 243: 388-90.
105. Laniado-Schwartzman M, Abraham NG, Sacerdoti D, Escalante B, McGiff JC. Effect of acute and chronic treatment of tin on blood pressure in spontaneously hypertensive rats. Tohoku J Exp Med 1992; 166:85-91.
106. da Silva JL, Tiefenthaler M, Park E, Escalante B, Schwartzman ML, Levere RD, et al. Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats. Am J Med Sci 1994; 307: 173-81.
107. Sessa WC, Abraham NG, Escalante B, Schwartzma ML. Manipulation of cytochrome P-450 dependent renal thromboxane synthase activity in spontaneously hypertensive rats. J Hypertens 1989; 7: 37-42.
108. Abraham NG. Therapeutic applications of human heme oxygenase gene transfer and gene therapy. Curr Pharm Des 2003; 9: 2513-24.
109. Kordac V, Kozakova M, Martasek P. Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration. Ann Med 1989; 21: 273-6.
110. Martasek P, Schwartzman ML, Goodman AI, Solangi KB, Levere RD, Abraham NG. Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J Am Soc Nephrol 1991; 2: 1078-84.
111. Schwartzman ML, Martasek P, Rios AR, Levere RD, Solangi K, Goodman AI, et al. Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int 1990; 37: 94-9.
112. Ndisang JF, Wu L, Zhao W, Wang R. Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 2003; 101: 3893-900.
113. Wang R, Shamloul R, Wang X, Meng Q, Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 2006; 48: 685-92.
114. Abraham NG, Mieyal PA, Quan S, Yang L, Burke-Wolin T, Mingone CJ, et al. Modulation of cyclic GMP by retrovirus-mediated human heme oxgyenase-1 gene transfer in microvessel endothelial cells. Am J Physiol 2002; 283: L1117-L1124.
115. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 1990; 86: 213-90.
116. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 2007; 50: 636-42.
117. Drummond GS, Kappas A. The cytochrome P-450-depleted animal: An experimental model for in vivo studies in chemical biology. Proc Natl Acad Sci USA 1982; 79: 2384-8.
118. Lin JH, Villalon P, Martasek P, Abraham NG. Regulation of heme oxygenase gene expression by cobalt in rat liver and kidney. Eur J Biochem 1990; 192: 577-82.
119. Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem 1988; 20: 543-58.
120. Abraham NG, Friedland ML, Levere RD. Heme metabolism in hepatic and erythroid cells. In: Brown E, editor. Progress in Hematology. Vol.XIII ed. New York: Grune and Stratton 1983; pp. 75-130.
121. Abraham N, Li M, Kim D, Kawakami T, Tsenovoy P, Rodella L, et al. Adiponectin is a downstream signal for heme oxygenase-1-mediated vascular protection. Diabetes Res Clin Pract 2008; (submitted).
122. Kappas A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics 2004; 113: 119-23.
123. Ishida H, Takizawa M, Ozawa S, Nakamichi Y, Yamaguchi S, Katsuta H, et al. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress. Metabolism 2004; 53: 488-94.
124. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, et al. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 2003; 308: 956-60.
125. Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, Fierro IM. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am J Physiol. Cell Physiol 2005; 289: C557-C563.
126. Becker JC, Grosser N, Boknik P, Schroder H, Domschke W, Pohle T. Gastroprotection by vitamin C - a heme oxygenase-1 -dependent mechanism? Biochem Biophys Res Commun 2003; 312: 507-12.
127. Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schurgerc S, et al. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med 2004; 37: 2064-71.
128. Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkelmann U, Smith G, et al. Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun 2004; 325: 871-6.
129. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004; 110: 1296-302.
130. Oberle S, Abate A, Grosser N, Hemmerle A, Vreman HJ, Dennery PA, et al. Endothelial protection by pentaerithrityl trinitrate: Bilirubin and carbon monoxide as possible mediators. Exp Biol Med (Maywood) 2003; 228: 529-34.
131. Hsu M, Machova L, Morioka I, Wong RJ, Schroder H, Stevenson DK. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Cornmun 2006; 343: 738-44.
132. Choi BM, Kim YM, Jeong YR. Pac HO, Song CE, Park JE, et al. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun 2004; 321: 132-7.
133. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 2006; 203: 1117-27.
134. Ishizaka N, De Leon H, Laurzen JB, Fukui T, Wilcox JN, De Keulenaer G, et al. Angiotensin if-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 1997; 96: 1923-9.
135. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban HE, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
136. Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, Motterlini R. Caffeic acid phenethyl ester and curcumin: A novel class of heme oxygenase-1 inducers. Mol Pharmacol 2002; 61: 554-61.
137. Motterlini R, Foresti R, Bassi R, Green CJ Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000; 28: 1303-12.
138. Das S, Fraga CG, Das DK. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res 2006; 40: 1066-75.
139. Kaga S, Zhan L, Matsumoto M, Maulik N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 2005; 39: 813-22.
140. Huang HM, Liang YC, Cheng TH, Chen CH, Juan SH. Potential mechanism of blood vessel protection by resveratrol, a component of red wine. Ann N Y Acad Sci 2005; 1042: 349-56.
141. Barbaro G. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome. Curr Pharm Des 2007; 13(21): 2208-13.
142. Chaldakov GN, Fiore M, Tonchev AB, Dimitrov D, Pancheva R, Rancic G, et al. Homo obesus: A metabotrophin-deficient species. Pharmacology and nutrition insight. Curr Pharm Des 2007; 13(21): 2176-9.
143. Kukarni RG, Achaiah G, Sastry G N. Novel targets for antiinflammatory and antiarthritic agents. Curr Pharm Des 2006; 12(19): 2437-54.